Comparison of propofol , droperidol , and metoclopramide for <font color="blue">prophylaxis_1</font> <font color="blue">of_1</font> <font color="blue">postoperative_2</font> <font color="blue">nausea_2</font> <font color="blue">and_2</font> <font color="blue">vomiting_2</font> <font color="blue">after_2</font> <font color="blue">breast_3</font> <font color="blue">cancer_3</font> <font color="blue">surgery_2</font> <font color="blue">:_2</font> a prospective , randomized , double - blind , placebo - controlled study in <font color="blue">Japanese_4</font> <font color="blue">patients_4</font> <font color="blue">._4</font> 
<br>
<br> BACKGROUND <font color="blue">Breast_1</font> <font color="blue">cancer_1</font> <font color="blue">surgery_1</font> <font color="blue">performed_1</font> <font color="blue">with_1</font> <font color="blue">the_1</font> <font color="blue">patient_3</font> <font color="blue">under_2</font> <font color="blue">general_2</font> <font color="blue">anesthesia_2</font> <font color="blue">has_1</font> <font color="blue">been_1</font> <font color="blue">associated_1</font> <font color="blue">with_1</font> <font color="blue">a_1</font> <font color="blue">relatively_1</font> <font color="blue">high_1</font> <font color="blue">incidence_1</font> <font color="blue">of_1</font> <font color="blue">postoperative_1</font> <font color="blue">nausea_1</font> <font color="blue">and_1</font> <font color="blue">vomiting_1</font> <font color="blue">(_1</font> <font color="blue">PONV_1</font> <font color="blue">)_1</font> <font color="blue">._1</font> Between <font color="blue">60%_1</font> <font color="blue">and_1</font> <font color="blue">80%_1</font> <font color="blue">of_1</font> <font color="blue">patients_2</font> <font color="blue">who_1</font> <font color="blue">undergo_1</font> <font color="blue">mastectomy_1</font> <font color="blue">(_1</font> <font color="blue">with_1</font> <font color="blue">axillary_1</font> <font color="blue">dissection_1</font> <font color="blue">)_1</font> <font color="blue">experience_1</font> <font color="blue">PONV_1</font> <font color="blue">._1</font> We previously reported that propofol at a subhypnotic dose of 0.5 mg / kg was more effective than placebo in preventing PONV in women who undergo mastectomy . 
<br> OBJECTIVE The purpose of this study was to compare the efficacy of a subhypnotic dose of propofol with the conventional antiemetics droperidol and metoclopramide for the prophylaxis of PONV after <font color="blue">breast_2</font> <font color="blue">cancer_2</font> <font color="blue">surgery_2</font> <font color="blue">in_2</font> <font color="blue">Japanese_2</font> <font color="blue">patients_2</font> <font color="blue">._2</font> <font color="blue">
<br>_1</font> METHODS In this prospective , randomized , double - blind , placebo - controlled study , <font color="blue">Japanese_3</font> <font color="blue">women_3</font> were randomized to <font color="blue">1_1</font> <font color="blue">of_1</font> <font color="blue">4_1</font> <font color="blue">groups_1</font> to receive IV administration of propofol 0.5 mg / kg , droperidol 20 microg / kg , metoclopramide 0.2 mg / kg , or placebo ( isotonic saline ) immediately after skin suture . <font color="blue">A_1</font> <font color="blue">standard_1</font> <font color="blue">general_1</font> <font color="blue">anesthetic_1</font> <font color="blue">technique_1</font> <font color="blue">,_1</font> <font color="blue">including_1</font> <font color="blue">sevoflurane_1</font> <font color="blue">and_1</font> <font color="blue">air_1</font> <font color="blue">in_1</font> <font color="blue">oxygen_1</font> <font color="blue">,_1</font> <font color="blue">was_1</font> <font color="blue">used_1</font> <font color="blue">._1</font> All episodes of PONV during the first 24 hours after anesthesia administration were recorded by an investigator who was blinded to treatment assignment . The investigator questioned the <font color="blue">patients_1</font> as to whether they experienced extrapyramidal symptoms . To maintain the integrity of the study results , none of the patients received preanesthetic medication . 
<br> RESULTS <font color="blue">A_2</font> <font color="blue">total_3</font> <font color="blue">of_3</font> <font color="blue">100_6</font> <font color="blue">women_6</font> <font color="blue">(_5</font> <font color="blue">mean_5</font> <font color="blue">[_5</font> <font color="blue">SD_5</font> <font color="blue">]_5</font> <font color="blue">age_5</font> <font color="blue">,_5</font> <font color="blue">52_5</font> <font color="blue">[_5</font> <font color="blue">7_5</font> <font color="blue">]_5</font> <font color="blue">years_5</font> <font color="blue">;_5</font> <font color="blue">height_5</font> <font color="blue">,_5</font> <font color="blue">154_5</font> <font color="blue">[_5</font> <font color="blue">6_5</font> <font color="blue">]_5</font> <font color="blue">cm_5</font> <font color="blue">;_5</font> <font color="blue">weight_5</font> <font color="blue">,_5</font> <font color="blue">54_5</font> <font color="blue">[_5</font> <font color="blue">7_5</font> <font color="blue">]_5</font> <font color="blue">kg_5</font> <font color="blue">)_5</font> <font color="blue">were_2</font> <font color="blue">included_2</font> <font color="blue">in_2</font> <font color="blue">the_2</font> <font color="blue">study_2</font> <font color="blue">._2</font> Each study <font color="blue">group_1</font> comprised 25 <font color="blue">patients_1</font> <font color="blue">._1</font> There were no significant differences between treatment <font color="blue">groups_1</font> with regard to patient demographics , surgery type , or awakening time . The prevalences of PONV 0 to 24 hours after anesthesia were 28% with propofol ( P = 0.005 ) , 32% with droperidol ( P = 0.011 ) , and 60% with metoclopramide ( P = NS ) , compared with placebo ( 68% ) . No significant difference in the prevalence of PONV was found between <font color="blue">patients_1</font> receiving propofol and those receiving droperidol , and propofol and droperidol were associated with significantly lower prevalences of PONV compared with metoclopramide ( P = 0.022 and P = 0.043 , respectively ) . Extrapyramidal symptoms were not reported in any of the groups . 
<br> CONCLUSIONS The prevalences of PONV were not significantly different between propofol 0.5 mg / kg and droperidol 20 microg / kg 0 to 24 hours after anesthesia in this small , select group of Japanese women who underwent breast cancer surgery . The prevalences of PONV were significantly lower with propofol and droperidol compared with metoclopramide 0.2 mg / kg and placebo .